(Q53616295)

16 May 2018

title

Physicians' attitudes toward clinical trials and their relationship to patient accrual in a Nordic multicenter study on myeloma. (English)

1 reference

16 May 2018

multicenter clinical trial

main subject

1 reference

2

1 reference

16 May 2018

author name string

Hjorth M

1

1 reference

16 May 2018

Rödjer S

3

1 reference

16 May 2018

Taube A

4

1 reference

16 May 2018

Westin J

5

1 reference

16 May 2018

language of work or name

English

0 references

publication date

1 October 1996

1 reference

16 May 2018

Contemporary Clinical Trials

published in

1 reference

16 May 2018

volume

17

1 reference

16 May 2018

issue

5

1 reference

16 May 2018

page(s)

372-386

1 reference

16 May 2018

Recruitment experience in clinical trials: literature summary and annotated bibliography

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900022-0

7 January 2021

National Cancer Institute sponsored cooperative clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900022-0

7 January 2021

Viability of cancer clinical research: patient accrual, coverage, and reimbursement. American Medical Association Council on Scientific Affairs

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900022-0

7 January 2021

Accrual of patients into a multihospital cancer clinical trial and its implications on planning future studies

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900022-0

7 January 2021

Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900022-0

7 January 2021

Clinical trials in cancer therapy: efforts to improve patient enrollment by community oncologists

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900022-0

7 January 2021

Attitudes toward clinical trials among patients and the public

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900022-0

7 January 2021

Interferon-alpha 2b added to melphalan-prednisone for initial and maintenance therapy in multiple myeloma. A randomized, controlled trial. The Nordic Myeloma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900022-0

7 January 2021

Patient accrual and quality of participation in a multicentre study on myeloma: a comparison between major and minor participating centres

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900022-0

7 January 2021

Impact of active and passive exclusions on the results of a clinical trial in multiple myeloma. The Myeloma Group of Western Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900022-0

7 January 2021

Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900022-0

7 January 2021

Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900022-0

7 January 2021

A New Design for Randomized Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900022-0

7 January 2021

The ethics of the randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900022-0

7 January 2021

Clinical trials. Access and reimbursement

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900022-0

7 January 2021

10.1016/S0197-2456(96)00022-0

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018